The Indian Pharmaceutical Sector : Issues and Options for Health Sector Reform
This report assesses the pharmaceutical sector in India, particularly focusing on four key issues related to the production, procurement, and distribution of drugs in India: a) availability, b) affordability; c) quality, and d) the rational use of...
| Main Authors: | , |
|---|---|
| Format: | Publication |
| Language: | English en_US |
| Published: |
Washington, DC: World Bank
2013
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/2002/09/2018943/indian-pharmaceutical-sector-issues-options-health-sector-reform http://hdl.handle.net/10986/15231 |
| id |
okr-10986-15231 |
|---|---|
| recordtype |
oai_dc |
| spelling |
okr-10986-152312021-04-23T14:03:11Z The Indian Pharmaceutical Sector : Issues and Options for Health Sector Reform Govindaraj, Ramesh Chellaraj, Gnanaraj PHARMACEUTICAL INDUSTRY PHARMACEUTICAL POLICY AFFORDABILITY AVAILABILITY DRUG LAW DRUG UTILIZATION QUALITY CONTROL DRUG PRICES INTERNATIONAL TRADE ACCOUNTING ADVERSE EFFECTS ADVERTISING BRAND NAME DRUGS CERTIFICATION CONTRACTING OUT COST SAVINGS DEVELOPED COUNTRIES DISCRIMINATION DISTRIBUTION OF PHARMACEUTICALS DRUG CONTROL DRUG INDUSTRY DRUG PRICES DRUG SELECTION DRUG UTILIZATION DRUGS ECONOMICS ESSENTIAL DRUGS EXPENDITURES GENERIC DRUGS GENERIC SUBSTITUTION GMP GOOD MANUFACTURING PRACTICES GOVERNMENT REGULATIONS HEALTH CARE HEALTH CARE COSTS HEALTH CARE FINANCING HEALTH CARE SERVICES HEALTH POLICY HEALTH SECTOR HOSPITALS HUMAN BEHAVIOUR HUMAN DEVELOPMENT IMPORTS INCOME INFORMAL SECTOR INNOVATION INSURANCE IRRATIONAL USE LABORATORIES LAWS LOCAL PRODUCTION MARKETING MEDICATION MEDICINAL DRUGS MEDICINES MINISTRIES OF HEALTH NATIONAL DRUG POLICIES NATIONAL DRUG POLICY NDP NURSING NUTRITION OIL PATENTS PHARMACEUTICAL COMPANIES PHARMACEUTICAL INDUSTRY PHARMACEUTICAL MANUFACTURERS PHARMACEUTICAL PATENTS PHARMACEUTICAL POLICIES PHARMACEUTICAL POLICY PHARMACEUTICAL QUALITY PHARMACEUTICAL QUALITY ASSURANCE PHARMACEUTICAL RESEARCH PHARMACEUTICAL SECTOR PHARMACEUTICAL SERVICES PHARMACEUTICAL SUPPLY PHARMACEUTICALS PHARMACEUTICALS PROCUREMENT PHARMACISTS PHARMACY PHARMACY CURRICULA PHARMACY SCHOOLS PHYSICIANS PILL POLICY INSTRUMENTS PRIVATE SECTOR PROCUREMENT PRODUCERS PROPERTY RIGHTS PUBLIC EDUCATION PUBLIC SECTOR PURCHASING QUALITY CONTROL RATIONAL USE OF DRUGS SAFETY SAFETY NETS SANCTIONS SOCIAL INSURANCE SOCIAL SERVICES SUSTAINABLE DEVELOPMENT TELECOMMUNICATIONS THERAPEUTICS TREATMENT GUIDELINES VACCINES This report assesses the pharmaceutical sector in India, particularly focusing on four key issues related to the production, procurement, and distribution of drugs in India: a) availability, b) affordability; c) quality, and d) the rational use of drugs. The results of a survey of three states indicate considerable variation across states in the above four areas in both public and private sectors. The report concludes that problems with the availability, affordability, and rational use of good quality, cost-effective, essential drugs have persisted in most parts of India, and that these health-related issues need be addressed as a priority. An overarching recommendation is the need to focus on strengthening the implementation and regulation of the pharmaceutical sector at the state level, rather than on simply introducing new regulations. Adequate pharmaceutical quality assurance needs to be particularly emphasized as, in its absence, other reform measures could be rendered moot. Similarly, the rational use of drugs needs to be emphasized as it is likely to yield significant cost savings to the government and to consumers, in addition to its positive impact on health. 2013-08-20T19:49:41Z 2013-08-20T19:49:41Z 2002-09 http://documents.worldbank.org/curated/en/2002/09/2018943/indian-pharmaceutical-sector-issues-options-health-sector-reform 0-8213-5212-1 0259-210X http://hdl.handle.net/10986/15231 English en_US World Bank Discussion Paper;No. 437 CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo World Bank Washington, DC: World Bank Publications & Research :: Publication Publications & Research :: Publication South Asia India |
| repository_type |
Digital Repository |
| institution_category |
Foreign Institution |
| institution |
Digital Repositories |
| building |
World Bank Open Knowledge Repository |
| collection |
World Bank |
| language |
English en_US |
| topic |
PHARMACEUTICAL INDUSTRY PHARMACEUTICAL POLICY AFFORDABILITY AVAILABILITY DRUG LAW DRUG UTILIZATION QUALITY CONTROL DRUG PRICES INTERNATIONAL TRADE ACCOUNTING ADVERSE EFFECTS ADVERTISING BRAND NAME DRUGS CERTIFICATION CONTRACTING OUT COST SAVINGS DEVELOPED COUNTRIES DISCRIMINATION DISTRIBUTION OF PHARMACEUTICALS DRUG CONTROL DRUG INDUSTRY DRUG PRICES DRUG SELECTION DRUG UTILIZATION DRUGS ECONOMICS ESSENTIAL DRUGS EXPENDITURES GENERIC DRUGS GENERIC SUBSTITUTION GMP GOOD MANUFACTURING PRACTICES GOVERNMENT REGULATIONS HEALTH CARE HEALTH CARE COSTS HEALTH CARE FINANCING HEALTH CARE SERVICES HEALTH POLICY HEALTH SECTOR HOSPITALS HUMAN BEHAVIOUR HUMAN DEVELOPMENT IMPORTS INCOME INFORMAL SECTOR INNOVATION INSURANCE IRRATIONAL USE LABORATORIES LAWS LOCAL PRODUCTION MARKETING MEDICATION MEDICINAL DRUGS MEDICINES MINISTRIES OF HEALTH NATIONAL DRUG POLICIES NATIONAL DRUG POLICY NDP NURSING NUTRITION OIL PATENTS PHARMACEUTICAL COMPANIES PHARMACEUTICAL INDUSTRY PHARMACEUTICAL MANUFACTURERS PHARMACEUTICAL PATENTS PHARMACEUTICAL POLICIES PHARMACEUTICAL POLICY PHARMACEUTICAL QUALITY PHARMACEUTICAL QUALITY ASSURANCE PHARMACEUTICAL RESEARCH PHARMACEUTICAL SECTOR PHARMACEUTICAL SERVICES PHARMACEUTICAL SUPPLY PHARMACEUTICALS PHARMACEUTICALS PROCUREMENT PHARMACISTS PHARMACY PHARMACY CURRICULA PHARMACY SCHOOLS PHYSICIANS PILL POLICY INSTRUMENTS PRIVATE SECTOR PROCUREMENT PRODUCERS PROPERTY RIGHTS PUBLIC EDUCATION PUBLIC SECTOR PURCHASING QUALITY CONTROL RATIONAL USE OF DRUGS SAFETY SAFETY NETS SANCTIONS SOCIAL INSURANCE SOCIAL SERVICES SUSTAINABLE DEVELOPMENT TELECOMMUNICATIONS THERAPEUTICS TREATMENT GUIDELINES VACCINES |
| spellingShingle |
PHARMACEUTICAL INDUSTRY PHARMACEUTICAL POLICY AFFORDABILITY AVAILABILITY DRUG LAW DRUG UTILIZATION QUALITY CONTROL DRUG PRICES INTERNATIONAL TRADE ACCOUNTING ADVERSE EFFECTS ADVERTISING BRAND NAME DRUGS CERTIFICATION CONTRACTING OUT COST SAVINGS DEVELOPED COUNTRIES DISCRIMINATION DISTRIBUTION OF PHARMACEUTICALS DRUG CONTROL DRUG INDUSTRY DRUG PRICES DRUG SELECTION DRUG UTILIZATION DRUGS ECONOMICS ESSENTIAL DRUGS EXPENDITURES GENERIC DRUGS GENERIC SUBSTITUTION GMP GOOD MANUFACTURING PRACTICES GOVERNMENT REGULATIONS HEALTH CARE HEALTH CARE COSTS HEALTH CARE FINANCING HEALTH CARE SERVICES HEALTH POLICY HEALTH SECTOR HOSPITALS HUMAN BEHAVIOUR HUMAN DEVELOPMENT IMPORTS INCOME INFORMAL SECTOR INNOVATION INSURANCE IRRATIONAL USE LABORATORIES LAWS LOCAL PRODUCTION MARKETING MEDICATION MEDICINAL DRUGS MEDICINES MINISTRIES OF HEALTH NATIONAL DRUG POLICIES NATIONAL DRUG POLICY NDP NURSING NUTRITION OIL PATENTS PHARMACEUTICAL COMPANIES PHARMACEUTICAL INDUSTRY PHARMACEUTICAL MANUFACTURERS PHARMACEUTICAL PATENTS PHARMACEUTICAL POLICIES PHARMACEUTICAL POLICY PHARMACEUTICAL QUALITY PHARMACEUTICAL QUALITY ASSURANCE PHARMACEUTICAL RESEARCH PHARMACEUTICAL SECTOR PHARMACEUTICAL SERVICES PHARMACEUTICAL SUPPLY PHARMACEUTICALS PHARMACEUTICALS PROCUREMENT PHARMACISTS PHARMACY PHARMACY CURRICULA PHARMACY SCHOOLS PHYSICIANS PILL POLICY INSTRUMENTS PRIVATE SECTOR PROCUREMENT PRODUCERS PROPERTY RIGHTS PUBLIC EDUCATION PUBLIC SECTOR PURCHASING QUALITY CONTROL RATIONAL USE OF DRUGS SAFETY SAFETY NETS SANCTIONS SOCIAL INSURANCE SOCIAL SERVICES SUSTAINABLE DEVELOPMENT TELECOMMUNICATIONS THERAPEUTICS TREATMENT GUIDELINES VACCINES Govindaraj, Ramesh Chellaraj, Gnanaraj The Indian Pharmaceutical Sector : Issues and Options for Health Sector Reform |
| geographic_facet |
South Asia India |
| relation |
World Bank Discussion Paper;No. 437 |
| description |
This report assesses the pharmaceutical
sector in India, particularly focusing on four key issues
related to the production, procurement, and distribution of
drugs in India: a) availability, b) affordability; c)
quality, and d) the rational use of drugs. The results of a
survey of three states indicate considerable variation
across states in the above four areas in both public and
private sectors. The report concludes that problems with the
availability, affordability, and rational use of good
quality, cost-effective, essential drugs have persisted in
most parts of India, and that these health-related issues
need be addressed as a priority. An overarching
recommendation is the need to focus on strengthening the
implementation and regulation of the pharmaceutical sector
at the state level, rather than on simply introducing new
regulations. Adequate pharmaceutical quality assurance needs
to be particularly emphasized as, in its absence, other
reform measures could be rendered moot. Similarly, the
rational use of drugs needs to be emphasized as it is likely
to yield significant cost savings to the government and to
consumers, in addition to its positive impact on health. |
| format |
Publications & Research :: Publication |
| author |
Govindaraj, Ramesh Chellaraj, Gnanaraj |
| author_facet |
Govindaraj, Ramesh Chellaraj, Gnanaraj |
| author_sort |
Govindaraj, Ramesh |
| title |
The Indian Pharmaceutical Sector : Issues and Options for Health Sector Reform |
| title_short |
The Indian Pharmaceutical Sector : Issues and Options for Health Sector Reform |
| title_full |
The Indian Pharmaceutical Sector : Issues and Options for Health Sector Reform |
| title_fullStr |
The Indian Pharmaceutical Sector : Issues and Options for Health Sector Reform |
| title_full_unstemmed |
The Indian Pharmaceutical Sector : Issues and Options for Health Sector Reform |
| title_sort |
indian pharmaceutical sector : issues and options for health sector reform |
| publisher |
Washington, DC: World Bank |
| publishDate |
2013 |
| url |
http://documents.worldbank.org/curated/en/2002/09/2018943/indian-pharmaceutical-sector-issues-options-health-sector-reform http://hdl.handle.net/10986/15231 |
| _version_ |
1764425322273439744 |